Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models

Many preclinically tested nanoparticles in existing animal models fail to be directly translated into clinical applications because of their poor resemblance to human cancer. Herein, the enhanced permeation and retention (EPR) effect of glycol chitosan nanoparticles (CNPs) in different tumor microenvironments (TMEs) was compared using different pancreatic tumor models, including pancreatic cancer cell line (BxPC3), patient-derived cancer cell (PDC), and patient-derived xenograft (PDX) models. CNPs were intravenously injected into different tumor models, and their accumulation efficiency was evaluated using non-invasive near-infrared fluorescence (NIRF) imaging. In particular, differences in angiogenic vessel density, collagen matrix, and hyaluronic acid content in tumor tissues of the BxPC3, PDC, and PDX models greatly affected the tumor-targeting efficiency of CNPs. In addition, different PDX models were established using different tumor tissues of patients to predict the clinical EPR effect of CNPs in inter-patient TMEs, wherein the gene expression levels of PECAM1, COL4A1, and HAS1 in human tumor tissues were observed to be closely related to the EPR effect of CNPs in PDX models. The results suggested that the PDX models could mimic inter-patient TMEs with different blood vessel structures and extracellular matrix (ECM) content that critically affect the tumor-targeting ability of CNPs in different pancreatic PDX models. This study provides a better understanding of the heterogeneity and complexity of inter-patient TMEs that can predict the response of various nanoparticles in individual tumors for personalized cancer therapy.

Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound

The dense extracellular matrix (ECM) in heterogeneous tumor tissues can prevent the deep tumor penetration of drug-loaded nanoparticles, resulting in a limited therapeutic efficacy in cancer treatment. Herein, we suggest that the deep tumor penetration of doxorubicin (DOX)-loaded glycol chitosan nanoparticles (CNPs) can be improved using high-intensity focused ultrasound (HIFU) technology. Firstly, we prepared amphiphilic glycol chitosan-5β-cholanic acid conjugates that can self-assemble to form stable nanoparticles with an average of 283.7 ± 5.3 nm. Next, the anticancer drug DOX was simply loaded into the CNPs via a dialysis method. DOX-loaded CNPs (DOX-CNPs) had stable nanoparticle structures with an average size of 265.9 ± 35.5 nm in aqueous condition. In cultured cells, HIFU-treated DOX-CNPs showed rapid drug release and enhanced cellular uptake in A549 cells, resulting in increased cytotoxicity, compared to untreated DOX-CNPs. In ECM-rich A549 tumor-bearing mice, the tumor-targeting efficacy of intravenously injected DOX-CNPs with HIFU treatment was 1.84 times higher than that of untreated DOX-CNPs. Furthermore, the deep tumor penetration of HIFU-treated DOX-CNPs was clearly observed at targeted tumor tissues, due to the destruction of the ECM structure via HIFU treatment. Finally, HIFU-treated DOX-CNPs greatly increased the therapeutic efficacy at ECM-rich A549 tumor-bearing mice, compared to free DOX and untreated DOX-CNPs. This deep penetration of drug-loaded nanoparticles via HIFU treatment is a promising strategy to treat heterogeneous tumors with dense ECM structures.

Aggregation-Driven Controllable Plasmonic Transition of Silica-Coated Gold Nanoparticles with Temperature-Dependent Polymer-Nanoparticle Interactions for Potential Applications in Optoelectronic Devices

Localized surface plasmon resonance (LSPR) effect relies on the shape, size, and dispersion state of metal nanoparticles and can potentially be employed in many applications such as chemical/biological sensor, optoelectronics, and photocatalyst. While complicated synthetic approaches changing shape and size of nanoparticles can control the intrinsic LSPR effect, here we show that controlling interparticle interactions with silica-coated gold nanoparticles (Au@SiO₂ NPs) is a powerful approach, permitting wide range of optical bandwidth of gold nanoparticles with great stability. The interparticle interactions of Au@SiO₂ NPs are controlled through concentration-, temperature-, and time-dependent polymer-induced interactions. The polymer-induced interactions modulate the state of particle dispersion, resulting an effective plasmonic shift by more than 200 nm. We further explore the microstructure of particle aggregation and explain mechanisms of plasmonic shift based on the results of small-angle X-ray scattering (SAXS) and discrete dipole approximation (DDA) calculation. We show that an effective control of LSPR behavior is now available through trapped aggregation of Au@SiO₂ NPs with temperature variation. We anticipate that the suggested strategy can be employed in many practical applications such as optical bioimaging and optoelectronic devices.

Non-thermal acoustic treatment as a safe alternative to thermosensitive liposome-involved hyperthermia for cancer therapy

Non-thermal acoustic treatment led to higher tissue penetration without permanent vascular damage and greater intratumoral drug accumulation than thermal treatment.

Gold-stabilized carboxymethyl dextran nanoparticles for image-guided photodynamic therapy of cancer

Photodynamic therapy (PDT) has been extensively investigated to treat cancer since it induces cell death through the activation of photosensitizers by light.

Non-covalent modification of graphene oxide nanocomposites with chitosan/dextran and its application in drug delivery

Graphene oxide nanosheets non-covalent functionalized with chitosan/dextran was successfully developed via LbL self-assembly technique for anti-cancer drug delivery application.